Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
deals
4
×
life sciences
national blog main
national top stories
sanofi
4
×
cancer
clinical trials
investing
new york blog main
new york top stories
roche
san francisco blog main
san francisco top stories
amgen
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
ipo
johnson & johnson
medicaid
national
novartis
president trump
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
What
drug
4
×
cancer
cash
medicines
roundup
acquire
agreed
ahead
alzheimer’s
ambien
american
annual
asco
attendees
attention
billion
bio
biotech
brings
camp’s
chicago
cholesterol
city
clinical
combinations
community’s
companies
company
compound
days
deal
despite
different
expanding
fail
family
fda
focus
gene
hardest
Language
unset
Current search:
sanofi
×
drug
×
deals
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More